National Institute on Minority Health and Health Disparities (NIMHD)
Age
18–99
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Women or men age \>18 years
Diagnosed with stage IV/metastatic breast cancer prescribed endocrine therapy and a CDK4/6i
Prescribed at least 1 antihypertensive or statin medication for CVD prevention or treatment
Self-report of at least some nonadherence ET/CDK4/6i or CVD medication on nonadherence screener or verbally to a treating clinician, or nonadherent to ET, CDK4/6i, and/or CVD medication on pharmacy fill data in the EHR (proportion of days covered over prior 180 days \<80%).
You may not be if
Non-English or Non-Spanish speaking
Not cognitively able to complete study requirements
Inability to provide informed consent for any other reason (e.g, severe psychiatric illness, active substance use)
Unavailable for 28 weeks of follow-up
Clareo Health | Adherence Intervention in Patients With Metastatic Breast Cancer
